Dermatol. praxi. 2009;3(2):78-82

Albright hereditary osteodystrophy

MUDr. Denisa Kacerovská, Ph.D, doc. MUDr. Dmitry V. Kazakov, Ph.D, Mgr. Jana Němcová, prof. MUDr. Michal Michal
Bioptická laboratoř s. r. o., Plzeň

Osteoma cutis is the formation of normal bone in the skin. Primary osteoma cutis occurs de novo, whereas the secondary type develops

in association with the underlying tumorous, inflammatory, or traumatic conditions. Primary osteomas may also be associated with

Albright´s hereditary osteodystrophy (AHO), which includes hypoparathyroidismus (PHP) type Ia and Ic, and pseudopseudohypoparathyroidismus

(PPHP). This review summarizes pathogenesis of PHP and emphasizes on clinical and histopathological findings in AHO.

In addition, a case of osteoma cutis involving in a 4-year-old boy and his mother who had cutaneous, biochemical and histopathological

features of PHP type Ia and PPHP is described. In this family, a novel mutation in the GNAS1 gene was also identified.

Keywords: Albright hereditary osteodystrophy, multiple osteoma cutis, calcification, GNAS1 gene.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kacerovská D, Kazakov DV, Němcová J, Michal M. Albright hereditary osteodystrophy. Dermatol. praxi. 2009;3(2):78-82.
Download citation

References

  1. Albright F, Burnett CH, Smith PH et al. Pseudohypoparathyroi?dism - an example of, ,Seabrightbantam syndrome": report of three cases. Endocrinology 1942; 30: 922-932.
  2. De Sanctis L, Romagnolo D, Olivero M, Buzi F, Maghnie M, Scire G, Crino A, Baroncelli GI, Salerno M, Di Maio S, Cappa M, Grosso S, Rigon F, Lala R, De Sanctis C, Dianzani I. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatr Res 2003; 53: 749-755. Go to original source... Go to PubMed...
  3. Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism. Horm Res 2005; 63: 65-74. Go to original source... Go to PubMed...
  4. Garavelli L, Pedori S, Zanacca C, Caselli G, Loiodice A, Mantovani G, Ammenti A, Virdis R, Banchini G. Albright's hereditary osteodystrophy (pseudohypoparathyroidism type Ia): clinical case with a novel mutation of GNAS1. Acta Biomed 2005; 76: 45-48.
  5. Wilson LC, Hall CM. Albright's hereditary osteodystrophy and pseudohypoparathyroidism. Semin Musculoskelet Radiol 2002; 6: 273-283. Go to original source... Go to PubMed...
  6. Gomes MF, Camargo AM, Sampaio TA, Graziozi MA, Armond MC. Oral manifestations of Albright hereditary osteodystrophy: a case report. Rev Hosp Clin Fac Med Sao Paulo 2002; 57: 161-166. Go to original source... Go to PubMed...
  7. Kapoor S, Gogia S, Paul R, Banerjee S. Albright's hereditary osteodystrophy. Indian J Pediatr 2006; 73: 153-156. Go to original source... Go to PubMed...
  8. Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Bourne HR. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. N Engl J Med 1980; 303: 237-242. Go to original source... Go to PubMed...
  9. Fischer JA, Bourne HR, Dambacher MA, Tschopp F, De Meyer R, Devogelaer JP, Werder EA, Nagant De Deuxchaisnes C. Pseudohypoparathyroidism: inheritance and expression of deficient receptor-cyclase coupling protein activity. Clin Endocrinol (Oxf) 1983; 19: 747-754. Go to original source... Go to PubMed...
  10. Levine MA, Downs RW, Jr., Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983; 74: 545-556. Go to original source... Go to PubMed...
  11. Levine MA, Jap TS, Mauseth RS, Downs RW, Spiegel AM. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986; 62: 497-502. Go to original source... Go to PubMed...
  12. Radeke HH, Auf'mkolk B, Juppner H, Krohn HP, Keck E, Hesch RD. Multiple pre- and postreceptor defects in pseudohypoparathyroidism (a multicenter study with twenty four patients). J Clin Endocrinol Metab 1986; 62: 393-402. Go to original source... Go to PubMed...
  13. Silve C, Santora A, Breslau N, Moses A, Spiegel A. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 1986; 62: 640-644. Go to original source... Go to PubMed...
  14. Juppner H, Schipani E, Bastepe M, Cole DE, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR, Vikkula M. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 1998; 95: 11798-11803. Go to original source... Go to PubMed...
  15. Lania A, Mantovani G, Spada A. G protein mutations in endocrine diseases. Eur J Endocrinol 2001; 145: 543-559. Go to original source... Go to PubMed...
  16. Liu J, Nealon JG, Weinstein LS. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 2005; 14: 95-102. Go to original source... Go to PubMed...
  17. de Wijn EM, Steendijk R. Growth and maturation in pseudo-hypoparathyroidism: a longitudinal study in 5 patients. Acta Endocrinol (Copenh) 1982; 101: 223-226. Go to original source... Go to PubMed...
  18. Fitch N. Albright's hereditary osteodystrophy: a review. Am J Med Genet 1982; 11: 11-29. Go to original source... Go to PubMed...
  19. Wilson LC. Albright's hereditary osteodystrophy. J Pediatr Endocrinol Metab 2006; 19(Suppl 2): 671-673. Go to original source... Go to PubMed...
  20. Barranco VP. Cutaneous ossification in pseudohypoparathyroidism. Arch Dermatol 1971; 104: 643-647. Go to original source... Go to PubMed...
  21. Eyre WG, Reed WB. Albright's hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol 1971; 104: 634-642. Go to original source... Go to PubMed...
  22. Goeteyn V, De Potter CR, Naeyaert JM. Osteoma cutis in pseudohypoparathyroidism. Dermatology 1999; 198: 209-211. Go to original source... Go to PubMed...
  23. Lucky AW, Tsang R. Pseudopseudohypoparathyroidism, presenting with osteoma cutis. J Bone Miner Res 1997; 12: 995. Go to original source... Go to PubMed...
  24. Piesowicz AT. Pseudo-Pseudo-Hypoparathyroidism with Osteoma Cutis. Proc R Soc Med 1965; 58: 126-128. Go to original source... Go to PubMed...
  25. Poomthavorn P, Zacharin M. Early manifestation of obesity and calcinosis cutis in infantile pseudohypoparathyroidism. J Paediatr Child Health 2006; 42: 821-823. Go to original source... Go to PubMed...
  26. Prendiville JS, Lucky AW, Mallory SB, Mughal Z, Mimouni F, Langman CB. Osteoma cutis as a presenting sign of pseudohypoparathyroidism. Pediatr Dermatol 1992; 9: 11-18. Go to original source... Go to PubMed...
  27. Sethuraman G, Malhotra AK, Khaitan BK, Kumar R, Sharma VK, Kabra M, Singh MK. Osteoma cutis in pseudohypoparathyroidism. Clin Exp Dermatol 2006; 31: 225-227. Go to original source... Go to PubMed...
  28. Steinbach HL, Rudhe U, Jonsson M, Young DA. Evolution of skeletal lesions in pseudohypoparathyroidism. Radiology 1965; 85: 670-676. Go to original source... Go to PubMed...
  29. Worret WI, Burgdorf W. Congenital, plaque-like osteoma of the skin in an infant. Hautarzt 1978; 29: 590-596. Go to PubMed...
  30. Kacerovska D, Nemcova J, Pomahacova R, Michal M, Kazakov DV. Cutaneous and superficial soft tissue lesions associated with Albright hereditary osteodystrophy: clinicopathological and molecular genetic study of 4 cases, including a novel mutation of the GNAS gene. Am J Dermatopathol 2008; 30: 417-424. Go to original source... Go to PubMed...
  31. Wong S, Zakov ZN, Albert DM. Scleral and choroidal calcifications in a patient with pseudohypoparathyroidism. Br J Ophthalmol 1979; 63: 177-180. Go to original source... Go to PubMed...
  32. Schuster V, Sandhage K. Intracardiac calcifications in a case of pseudohypoparathyroidism type Ia (PHP-Ia). Pediatr Cardiol 1992; 13: 237-239. Go to original source... Go to PubMed...
  33. Farfel Z, Friedman E. Mental deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency. Ann Intern Med 1986; 105: 197-199. Go to original source... Go to PubMed...
  34. Koch T, Lehnhardt E, Bottinger H, Pfeuffer T, Palm D, Fischer B, Radeke H, Hesch RD. Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study. Eur J Clin Invest 1990; 20: 416-421. Go to original source... Go to PubMed...
  35. Faull CM, Welbury RR, Paul B, Kendall-Taylor P. Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med 1991; 78: 251-264.
  36. Ritchie GM. Dental manifestations of pseudohypoparathyroidism. Arch Dis Child 1965; 40: 565-572. Go to original source... Go to PubMed...
  37. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology 2004; 145: 5459-5464. Go to original source... Go to PubMed...
  38. Linglart A, Carel JC, Garabedian M, Le T, Mallet E, Kottler ML. GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab 2002; 87: 189-197. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.